 Antibodies
"Antibodies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
| Descriptor ID |
D000906
|
| MeSH Number(s) |
D12.776.124.486.485.114 D12.776.124.790.651.114 D12.776.377.715.548.114
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antibodies".
Below are MeSH descriptors whose meaning is more specific than "Antibodies".
- Antibodies
- Antibodies, Anti-Idiotypic
- Antibodies, Archaeal
- Antibodies, Bacterial
- Antibodies, Bispecific
- Antibodies, Blocking
- Antibodies, Catalytic
- Antibodies, Fungal
- Antibodies, Helminth
- Antibodies, Heterophile
- Antibodies, Immobilized
- Antibodies, Monoclonal
- Antibodies, Neoplasm
- Antibodies, Neutralizing
- Antibodies, Phospho-Specific
- Antibodies, Protozoan
- Antibodies, Viral
- Antigen-Antibody Complex
- Autoantibodies
- Immune Sera
- Immunoglobulin Allotypes
- Immunoglobulin Isotypes
- Immunoglobulins, Intravenous
- Insulin Antibodies
- Isoantibodies
- Oligoclonal Bands
- Opsonin Proteins
- Plantibodies
- Precipitins
- Reagins
This graph shows the total number of publications written about "Antibodies" by people in this website by year, and whether "Antibodies" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1992 | 2 | 1 | 3 | | 1993 | 2 | 1 | 3 | | 1994 | 1 | 5 | 6 | | 1995 | 1 | 7 | 8 | | 1996 | 2 | 2 | 4 | | 1997 | 0 | 5 | 5 | | 1998 | 1 | 2 | 3 | | 1999 | 0 | 4 | 4 | | 2000 | 1 | 8 | 9 | | 2001 | 1 | 3 | 4 | | 2002 | 0 | 6 | 6 | | 2003 | 0 | 7 | 7 | | 2004 | 4 | 12 | 16 | | 2005 | 5 | 7 | 12 | | 2006 | 2 | 4 | 6 | | 2007 | 1 | 3 | 4 | | 2008 | 3 | 8 | 11 | | 2009 | 2 | 3 | 5 | | 2010 | 3 | 3 | 6 | | 2011 | 2 | 1 | 3 | | 2012 | 3 | 3 | 6 | | 2013 | 3 | 8 | 11 | | 2014 | 3 | 8 | 11 | | 2015 | 6 | 3 | 9 | | 2016 | 4 | 3 | 7 | | 2017 | 4 | 3 | 7 | | 2018 | 5 | 3 | 8 | | 2019 | 5 | 2 | 7 | | 2020 | 2 | 0 | 2 | | 2021 | 3 | 2 | 5 | | 2022 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Antibodies" by people in Profiles.
-
Zheng Y, Song K, Cai K, Liu L, Tang D, Long W, Zhai B, Chen J, Tao Y, Zhao Y, Liang S, Huang Q, Liu Q, Zhang Q, Chen Y, Liu Y, Li H, Wang P, Lan K, Liu H, Xu K. B-Cell-Epitope-Based Fluorescent Quantum Dot Biosensors for SARS-CoV-2 Enable Highly Sensitive COVID-19 Antibody Detection. Viruses. 2022 05 12; 14(5).
-
Mawad W, Hornberger L, Cuneo B, Raboisson MJ, Moon-Grady AJ, Lougheed J, Diab K, Parkman J, Silverman E, Jaeggi E. Outcome of Antibody-Mediated Fetal Heart Disease With Standardized Anti-Inflammatory Transplacental Treatment. J Am Heart Assoc. 2022 02; 11(3):e023000.
-
Bu L, Gupta G, Pai A, Anand S, Stites E, Moinuddin I, Bowers V, Jain P, Axelrod DA, Weir MR, Wolf-Doty TK, Zeng J, Tian W, Qu K, Woodward R, Dholakia S, De Golovine A, Bromberg JS, Murad H, Alhamad T. Clinical outcomes from the Assessing Donor-derived cell-free DNA Monitoring Insights of kidney Allografts with Longitudinal surveillance (ADMIRAL) study. Kidney Int. 2022 04; 101(4):793-803.
-
Buchman TG, Draghia-Akli R, Adam SJ, Aggarwal NR, Fessel JP, Higgs ES, Menetski JP, Read SW, Hughes EA. Accelerating Coronavirus Disease 2019 Therapeutic Interventions and Vaccines-Selecting Compounds for Clinical Evaluation in Coronavirus Disease 2019 Clinical Trials. Crit Care Med. 2021 11 01; 49(11):1963-1973.
-
Yalamanoglu A, Dubach IL, Schulthess N, Ingoglia G, Swindle DC, Humar R, Schaer DJ, Buehler PW, Irwin DC, Vallelian F. Agonistic Anti-CD40 Antibody Triggers an Acute Liver Crisis With Systemic Inflammation in Humanized Sickle Cell Disease Mice. Front Immunol. 2021; 12:627944.
-
Witeof AE, Daniels AL, Rea LT, Movafaghi S, Kurtz K, Davis M, Eveland RW, Calderon CP, Randolph TW. Machine Learning and Accelerated Stress Approaches to Differentiate Potential Causes of Aggregation in Polyclonal Antibody Formulations During Shipping. J Pharm Sci. 2021 07; 110(7):2743-2752.
-
Cara-Fuentes G, Smoyer WE. Biomarkers in pediatric glomerulonephritis and nephrotic syndrome. Pediatr Nephrol. 2021 09; 36(9):2659-2673.
-
Erickson CB, Newsom JP, Fletcher NA, Yu Y, Rodriguez-Fontan F, Weatherford SA, Hadley-Miller N, Krebs MD, Payne KA. Anti-VEGF antibody delivered locally reduces bony bar formation following physeal injury in rats. J Orthop Res. 2021 08; 39(8):1658-1668.
-
Daniels AL, Calderon CP, Randolph TW. Machine learning and statistical analyses for extracting and characterizing "fingerprints" of antibody aggregation at container interfaces from flow microscopy images. Biotechnol Bioeng. 2020 11; 117(11):3322-3335.
-
Stites E, Renner B, Laskowski J, Le Quintrec M, You Z, Freed B, Cooper J, Jalal D, Thurman JM. Complement fragments are biomarkers of antibody-mediated endothelial injury. Mol Immunol. 2020 02; 118:142-152.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|